Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of anti-SARS-CoV-2 antibodies in infants born to vaccinated mothers
TCTR20230324006Unknown
- Sponsor
- National Vaccine Institute
- Start
- Mar 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by National Vaccine Institute. Primary endpoint: Persistence of anti-SARS-CoV-2 antibodies in infants. Status: unknown.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20230324006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230324006.